Follow
Brent L Wood
Brent L Wood
Professor of Laboratory Medicine, Childrens Hospital Los Angeles
Verified email at chla.usc.edu
Title
Cited by
Cited by
Year
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
CJ Turtle, LA Hanafi, C Berger, TA Gooley, S Cherian, M Hudecek, ...
The Journal of clinical investigation 126 (6), 2123-2138, 2016
15772016
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
J Zhang, L Ding, L Holmfeldt, G Wu, SL Heatley, D Payne-Turner, ...
Nature 481 (7380), 157-163, 2012
15602012
Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia
H Kantarjian, A Stein, N Gökbuget, AK Fielding, AC Schuh, JM Ribera, ...
New England Journal of Medicine 376 (9), 836-847, 2017
13072017
Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies
CC Pritchard, E Kroh, B Wood, JD Arroyo, KJ Dougherty, MM Miyaji, ...
Cancer prevention research 5 (3), 492-497, 2012
9082012
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
WC Liles, HE Broxmeyer, E Rodger, B Wood, K Hübel, S Cooper, ...
Blood 102 (8), 2728-2730, 2003
8532003
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells
CJ Turtle, LA Hanafi, C Berger, M Hudecek, B Pender, E Robinson, ...
Science translational medicine 8 (355), 355ra116-355ra116, 2016
8262016
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ...
Blood, The Journal of the American Society of Hematology 131 (12), 1275-1291, 2018
7652018
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
BG Till, MC Jensen, J Wang, EY Chen, BL Wood, HA Greisman, X Qian, ...
Blood, The Journal of the American Society of Hematology 112 (6), 2261-2271, 2008
7572008
The genomic landscape of hypodiploid acute lymphoblastic leukemia
L Holmfeldt, L Wei, E Diaz-Flores, M Walsh, J Zhang, L Ding, ...
Nature genetics 45 (3), 242-252, 2013
6712013
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Y Liu, J Easton, Y Shao, J Maciaszek, Z Wang, MR Wilkinson, ...
Nature genetics 49 (8), 1211-1218, 2017
5752017
Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor–modified T cells after failure of ibrutinib
CJ Turtle, KA Hay, LA Hanafi, D Li, S Cherian, X Chen, B Wood, ...
Journal of Clinical Oncology 35 (26), 3010, 2017
5432017
Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women
AM Troen, B Mitchell, B Sorensen, MH Wener, A Johnston, B Wood, ...
The Journal of nutrition 136 (1), 189-194, 2006
5202006
Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations
BL Wood, DF Gibson, JF Tait
5001996
Using synthetic templates to design an unbiased multiplex PCR assay
CS Carlson, RO Emerson, AM Sherwood, C Desmarais, MW Chung, ...
Nature communications 4 (1), 1-9, 2013
4952013
Identification of a human heme exporter that is essential for erythropoiesis
JG Quigley, Z Yang, MT Worthington, JD Phillips, KM Sabo, DE Sabath, ...
Cell 118 (6), 757-766, 2004
4552004
A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas
OW Press, JF Eary, T Gooley, AK Gopal, S Liu, JG Rajendran, ...
Blood, The Journal of the American Society of Hematology 96 (9), 2934-2942, 2000
3862000
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute …
RB Walter, TA Gooley, BL Wood, F Milano, M Fang, ML Sorror, EH Estey, ...
Journal of clinical oncology 29 (9), 1190, 2011
3722011
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Is It Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?
D Araki, BL Wood, M Othus, JP Radich, AB Halpern, Y Zhou, M Mielcarek, ...
Blood, The Journal of the American Society of Hematology 126 (23), 2571-2571, 2015
3482015
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
RB Walter, SA Buckley, JM Pagel, BL Wood, BE Storer, BM Sandmaier, ...
Blood, The Journal of the American Society of Hematology 122 (10), 1813-1821, 2013
3442013
Cord-blood transplantation in patients with minimal residual disease
F Milano, T Gooley, B Wood, A Woolfrey, ME Flowers, K Doney, ...
N Engl J Med 375, 944-953, 2016
3252016
The system can't perform the operation now. Try again later.
Articles 1–20